In this post, Fancy Comma, LLC’s Sheeva Azma talks about what neuroplasticity is and how it helps humans be more adaptable.
Category Archives: General Interest
Genuinely Simple Ways to Achieve Balance in a Pandemic
Dawn Beauchamp shares how she has been able to achieve balance amidst the chaos of parenting, work, and life during the COVID-19 pandemic.
In the COVID-19 Pandemic, Science Reporting Matters
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
The Simplified Guide to Understanding Statistics in the Social Sciences, Part I: Numbers and Graphs
In Part 1 of this two-part series, Fancy Comma, LLC’s Kelly Tabbutt discusses the simplest ways to understand numbers and graphs when interpreting statistics in the social sciences.
How the Novavax Vaccine for COVID-19, A Protein Subunit Vaccine, Works
In this post, Nidhi Parekh of The Shared Microscope talks about Novavax, a protein subunit vaccine being developed for COVID-19.
How Does China’s CoronaVac Vaccine for COVID-19 Work?
Learn more about CoronaVac, a COVID-19 inactivated vaccine being developed by Sinovac in China, in this post by Nidhi Parekh of The Shared Microscope.
5 Experts Muse about the Future of COVID-19
Is a post-COVID-19 world possible? Will COVID-19 become endemic? Should we have done it all differently? What about a vaccine? What are the major troubles we are facing? Nidhi Parekh of The Shared Microscope examines what the experts have to say on these questions.
What’s It Like to Participate in a Clinical Trial for a COVID-19 Vaccine?
We speak to a participant in the Oxford/AstraZeneca vaccine trials for COVID-19 about what it’s like.
How Does the Oxford University/AstraZeneca Vaccine for COVID-19 Work?
Nidhi Parekh of The Shared Microscope discusses the history of, and science behind, the Oxford/AstraZeneca vaccine for COVID-19.
How Does Moderna’s mRNA Vaccine for COVID-19 Work?
In this post, learn about how the Moderna COVID-19 vaccine works. and why this mRNA-based vaccine is a front-runner in the race to a COVID-19 vaccine to mitigate the ongoing novel coronavirus pandemic.